$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading Week 33/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. in week 33/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 308.13 | 350 | 107,844 | 1,596,582 | 1.6 M to 1.6 M (-0.02 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 307.06 | 14,640 | 4,495,314 | 1,596,932 | 1.6 M to 1.6 M (-0.91 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 306.23 | 525 | 160,772 | 1,611,572 | 1.6 M to 1.6 M (-0.03 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 305.14 | 1,732 | 528,501 | 1,612,097 | 1.6 M to 1.6 M (-0.11 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 303.77 | 1,193 | 362,394 | 1,613,829 | 1.6 M to 1.6 M (-0.07 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 302.55 | 1,100 | 332,806 | 1,615,022 | 1.6 M to 1.6 M (-0.07 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 301.42 | 1,710 | 515,426 | 1,616,122 | 1.6 M to 1.6 M (-0.11 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 300.21 | 3,985 | 1,196,329 | 1,617,832 | 1.6 M to 1.6 M (-0.25 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 298.61 | 100 | 29,861 | 1,621,817 | 1.6 M to 1.6 M (-0.01 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 297.76 | 9,985 | 2,973,134 | 1,621,917 | 1.6 M to 1.6 M (-0.61 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 296.86 | 6,192 | 1,838,139 | 1,631,902 | 1.6 M to 1.6 M (-0.38 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 296.21 | 7,062 | 2,091,814 | 1,638,094 | 1.6 M to 1.6 M (-0.43 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 294.96 | 3,254 | 959,800 | 1,645,156 | 1.6 M to 1.6 M (-0.20 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 293.85 | 4,468 | 1,312,908 | 1,648,410 | 1.7 M to 1.6 M (-0.27 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | SILVERSTEIN JONATHAN | Director | Sell | S | 292.70 | 3,704 | 1,084,165 | 1,652,878 | 1.7 M to 1.7 M (-0.22 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 308.13 | 350 | 107,844 | 1,596,582 | 1.6 M to 1.6 M (-0.02 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 307.06 | 14,640 | 4,495,314 | 1,596,932 | 1.6 M to 1.6 M (-0.91 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 306.23 | 525 | 160,772 | 1,611,572 | 1.6 M to 1.6 M (-0.03 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 305.14 | 1,732 | 528,501 | 1,612,097 | 1.6 M to 1.6 M (-0.11 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 303.77 | 1,193 | 362,394 | 1,613,829 | 1.6 M to 1.6 M (-0.07 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 302.55 | 1,100 | 332,806 | 1,615,022 | 1.6 M to 1.6 M (-0.07 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 301.42 | 1,710 | 515,426 | 1,616,122 | 1.6 M to 1.6 M (-0.11 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 300.21 | 3,985 | 1,196,329 | 1,617,832 | 1.6 M to 1.6 M (-0.25 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 298.61 | 100 | 29,861 | 1,621,817 | 1.6 M to 1.6 M (-0.01 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 297.76 | 9,985 | 2,973,134 | 1,621,917 | 1.6 M to 1.6 M (-0.61 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 296.86 | 6,192 | 1,838,139 | 1,631,902 | 1.6 M to 1.6 M (-0.38 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 296.21 | 7,062 | 2,091,814 | 1,638,094 | 1.6 M to 1.6 M (-0.43 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 294.96 | 3,254 | 959,800 | 1,645,156 | 1.6 M to 1.6 M (-0.20 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 293.85 | 4,468 | 1,312,908 | 1,648,410 | 1.7 M to 1.6 M (-0.27 %) |
| Aug 18 2014 | ICPT | INTERCEPT PHARMACE ... | ORBIMED ADVISORS LLC | Director | Sell | S | 292.70 | 3,704 | 1,084,165 | 1,652,878 | 1.7 M to 1.7 M (-0.22 %) |